bezafibrate has been researched along with EHS Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuzawa, K; Matsumoto, A; Noguchi, Y; Nomura, K; Tuburaya, A; Yoshida, S; Yoshikawa, T | 1 |
| Matsumoto, A; Noguchi, Y; Nomura, K | 1 |
| Hirst, DG; Schwartz, HC; Wood, PJ | 1 |
3 other study(ies) available for bezafibrate and EHS Tumor
| Article | Year |
|---|---|
[Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report].
Topics: Animals; Bezafibrate; Cachexia; Lipoprotein Lipase; Male; Methylcholanthrene; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1993 |
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
Topics: Animals; Bezafibrate; Energy Metabolism; Enzyme Induction; Hypolipidemic Agents; Lipoprotein Lipase; Male; Methylcholanthrene; Neoplasm Transplantation; Rats; Rats, Inbred F344; Sarcoma, Experimental; Triglycerides | 1996 |
The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs.
Topics: Animals; Bezafibrate; Clofibrate; Combined Modality Therapy; Gemfibrozil; Hemoglobins; Hypolipidemic Agents; Mice; Neoplasm Transplantation; Oxygen; Pentanoic Acids; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1987 |